Kobayashi Motoo, Okada Yuki, Ueno Hiromichi, Mizorogi Takayuki, Ohara Kenji, Kawasumi Koh, Suruga Kohei, Kadokura Kazunari, Ohnishi Yasuyuki, Arai Toshiro
Laboratory of Veterinary Biochemistry, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo 180-8601, Japan.
One Health Co. Ltd, Tokyo 157-0066, Japan.
Vet Med (Auckl). 2020 Mar 16;11:39-44. doi: 10.2147/VMRR.S240516. eCollection 2020.
Obesity has become a serious public health problem all over the world, and prevalence of obesity has increased in cats. Obesity is characterized by continuous low-grade inflammation based on oxidative stress by excessively produced reactive oxygen species (ROS). Supplementation with anti-oxidant and anti-inflammatory compounds is very effective to relieve the obesity condition. A plant extract mixture containing and some other herbs, Rv-PEM01-99, shows anti-oxidant and anti-inflammatory effects in animals. The aim of this study was to evaluate the effects of supplementation with Rv-PEM01-99 as an anti-inflammatory compound in healthy and obese cats.
Ten healthy mix breed cats and four obesity disease cats were used. The healthy cats were randomly divided into control and test groups. Anti-inflammatory compound, Rv-PEM01-99, in which quercetin derivative is the main component, was supplemented to the healthy test group and the obesity disease cats at the dose of 100-120 mg/kg/day (2.5-3.0 mg/kg/day as quercetin) for 4 weeks. Metabolites, hormones and enzymes were measured before and after the compound supplementation.
The anti-inflammatory compound supplementation decreased serum amyloid A (SAA) concentrations as inflammatory markers in both healthy and obesity disease cats. In obesity disease cats, plasma total cholesterol concentrations and AST and ALT activities decreased significantly after the compound supplementation.
Quercetin derivative seems to have strong anti-inflammatory activities. In the healthy cats, anti-inflammatory compound supplementation decreased plasma NEFA and SAA concentrations. In the obesity disease cats, the compound supplementation may have alleviated obesity disease by relieving inflammation and improvement of lipid metabolism in livers.
肥胖已成为全球严重的公共卫生问题,猫的肥胖患病率也在上升。肥胖的特征是基于过量产生的活性氧(ROS)引起的氧化应激导致持续的低度炎症。补充抗氧化和抗炎化合物对缓解肥胖状况非常有效。一种含有槲皮素和其他一些草药的植物提取物混合物Rv-PEM01-99在动物中显示出抗氧化和抗炎作用。本研究的目的是评估补充Rv-PEM01-99作为抗炎化合物对健康和肥胖猫的影响。
使用10只健康的混种猫和4只肥胖病猫。将健康猫随机分为对照组和试验组。以100 - 120 mg/kg/天(以槲皮素计为2.5 - 3.0 mg/kg/天)的剂量向健康试验组和肥胖病猫补充以槲皮素衍生物为主要成分的抗炎化合物Rv-PEM01-99,持续4周。在补充化合物前后测量代谢物、激素和酶。
补充抗炎化合物降低了健康猫和肥胖病猫作为炎症标志物的血清淀粉样蛋白A(SAA)浓度。在肥胖病猫中,补充化合物后血浆总胆固醇浓度以及AST和ALT活性显著降低。
槲皮素衍生物似乎具有强大的抗炎活性。在健康猫中,补充抗炎化合物降低了血浆非酯化脂肪酸(NEFA)和SAA浓度。在肥胖病猫中,补充该化合物可能通过减轻炎症和改善肝脏脂质代谢缓解了肥胖病。